Morning Hubsters, Happy Fri-yay! John R Fischer here with the US Wire from the New York newsroom. First up, let’s take a look at what fashion styles have caught the eye of Ares Management, Clayton, Dubilier & Rice, Neuberger Berman and others in Iris Dorbian’s five-deal listicle on the retail apparel sector. Earlier in the Europe edition, Sophie Rose also covered seven deals in the footwear segment. Next, we look at life sciences. Assets in the market have matured and now these companies are looking for investments to replenish their portfolios, creating new opportunities for private equity, according to BDO USA’s 2025 Life Sciences CFO Outlook Survey. We’ll finish off with a roundup of life science deals PE Hub has covered so far in 2025. Better visibility Whether it’s fundamental changes in consumer behavior or the covid-19 pandemic, the retail apparel sector has weathered numerous challenges. Yet, despite these disruptions, the sector still has a resiliency that attracts private equity, as evidenced by a slew of recent deals involving iconic fashion brands such as Vera Wang and Laura Ashley as targets. To learn more about private equity’s investment in the space, PE Hub’s Iris Dorbian spoke with Matthew Tingler, managing director in Baird’s global consumer investment banking group. In June 2024, we highlighted five deals in athleisure apparel. From that period to now, Dorbian rounded up five deals that PE Hub has tracked in the retail apparel sector. Also, earlier today, PE Hub’s Sophie Rose looked into a subsegment within retail apparel: footwear. You can find her seven-deal listicle here. Upgrade to the premium version of the Wire to learn more. Maturing assets Expiring patents may drive large pharma companies to pursue more business development deals and acquisitions to replenish their portfolios, according to assurance, tax, and financial advisory services provider BDO USA’s 2025 Life Sciences CFO Outlook Survey. To learn more, I spoke with Brad Stewart, BDO’s national life sciences co-leader. PE Hub has reported several deals in January and February in the life science sector. Here are three highlights: Blackstone sells Anthos to Novartis for up to $3.1bn Latticework and Edgehill invest in life science digital media biz Life Science Connect Astorg to buy Fujifilm Irvine Scientific’s Medical Media Business To read my takeaways from the survey, take a look at the premium Wire. That’s it from me. As always, if you have any questions, thoughts or want to chat, please email me at [email protected]. Craig McGlashan will be on Europe Wire duty on Monday, while MK Flynn will bring you the US edition. Cheers, John Read the full Wire commentary on PE Hub ... |